These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 6441072

  • 1. [Experience with diamicron treatment of diabetics].
    Velikov VK, Shubina IO, Saltykov BB, Frolova AI.
    Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
    [No Abstract] [Full Text] [Related]

  • 2. [Diamicron in the treatment of diabetes mellitus type 2].
    Balabolkin MI, Morozova TP, Chachiashvili MV.
    Sov Med; 1987 Nov; (7):21-2. PubMed ID: 3317910
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Diamicron and micristin in the complex treatment of diabetes mellitus].
    Balabolkin MI, Golubiatnikova GA, Koroleva TV, Titova GP.
    Ter Arkh; 1982 Nov; 54(10):32-6. PubMed ID: 7179117
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E, Schnell O.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes.
    Räkel A, Renier G, Roussin A, Buithieu J, Mamputu JC, Serri O.
    Diabetes Obes Metab; 2007 Jan; 9(1):127-9. PubMed ID: 17199728
    [No Abstract] [Full Text] [Related]

  • 12. [Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].
    Lesobre B.
    Journ Annu Diabetol Hotel Dieu; 1990 Jan; ():325-34. PubMed ID: 2195215
    [No Abstract] [Full Text] [Related]

  • 13. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
    Simonin R.
    Mars Med; 1972 Jan; 109(10):655-8. PubMed ID: 4659845
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Therapeutic value of a new hypoglycemic agent (gliclazide) in the treatment of diabetes mellitus].
    Polosa P, Mughini L.
    Clin Ter; 1978 Jan 31; 84(2):135-40. PubMed ID: 648096
    [No Abstract] [Full Text] [Related]

  • 16. [Hypoglycemic effect of diamicron in diabetic patients].
    Balabolkin MI, Morozova TP, Zhizhina SA, Gavriliuk LI.
    Klin Med (Mosk); 1983 Jan 31; 61(1):87-9. PubMed ID: 6834765
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Long-term ambulatory treatment of diabetics with gliclazide].
    Parodi FA.
    Clin Ter; 1979 Feb 15; 88(3):281-8. PubMed ID: 376219
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.